Yesterday the Georgia House voted 138–21 to pass SB 220, legislation that would significantly expand Georgia’s current medical marijuana program. The bill now returns to the Senate, where senators must decide whether to agree to the House version or disagree.
If the Senate agrees to the House changes, the bill would move directly to the Governor’s desk. If the Senate does not agree, a conference committee made up of members from both the House and Senate will be appointed to attempt to resolve the differences between the two versions.
Georgians for Responsible Marijuana Policy opposed the House substitute because it fundamentally changes Georgia’s current Low THC Oil program (limited to 5% THC) into a much broader “medical cannabis” program with no potency limit and an extremely broad definition of qualifying products. Our policy brief explained concerns that the bill could allow high-potency cannabis concentrates — often 70–90%+ THC in other states — to qualify as “medical cannabis.”
